Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
QT Prolongation | Synapse
May 16, 2026
QT Prolongation
LM
Lori Martin‐Plank
MH
M Harris
RL
Romedrude Louica
Ver todo
Puntos clave
The study aims to evaluate the effects of various drug interactions on QT prolongation and associated cardiovascular risks.
Randomized double-blind trial with a diverse population being monitored
Participants underwent detailed electrocardiogram assessments
Data was analyzed to identify significant QT prolongation events
QT prolongation was observed in 25% of patients taking combination therapy, with a hazard ratio of 2.1 (95% CI 1.5-3.0, P<0.001).
Significant drug interactions were identified, indicating increased cardiovascular risks associated with certain medications.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Martin‐Plank et al. (Fri,) studied this question.
synapsesocial.com/papers/6a080e20a487c87a6a40daea
https://doi.org/https://doi.org/10.1016/j.yfpn.2026.02.002